Recent studies suggest that vertebrate and invertebrate defensins have evolved from two independent ancestors, and that both defensins could share origins with animal toxins. Here, we purified novel sea anemone neurotoxin (BDS)-like antimicrobial peptides (AMPs)-Crassicorin-I and its putative homolog (Crassicorin-II)-from the pharynx extract of an anthozoan sea anemone (Urticina crassicornis). Based on structural analyses and cDNA cloning, mature Crassicorin-I represents a cationic AMP likely generated from a precursor and comprising 40 amino acid residues, including six cysteines forming three intramolecular disulfide bonds. Recombinant Crassicorin-I produced in a heterologous bacterial-expression system displayed antimicrobial activity against both a gram-positive bacterium (Bacillus subtilis) and gram-negative bacteria (Escherichia coli and Salmonella enterica). The Crassicorin-I transcript was upregulated by immune challenge, suggesting its involvement in defense mechanisms against infectious pathogens in sea anemone. Sequence alignment and three-dimensional molecular modeling revealed that Crassicorin-I exhibits high degrees of structural similarity to sea anemone neurotoxins that share b-defensin fold which is found in vertebrate defensins and invertebrate big-defensins. Consistent with its structural similarity to neurotoxins, Crassicorin-I exhibited paralytic activity toward a crustacean. These findings motivated our investigation and subsequent discovery of antimicrobial activity from other known sea anemone neurotoxins, such as APETx1 and ShK. Collectively, our work signified that Crassicorin-I is the first AMP identified from a sea anemone and provided evidence of a functional linkage between AMPs and neurotoxins in a basally branching metazoan.
Introduction
Antimicrobial peptides (AMPs) are evolutionarily ancient molecules produced by a wide variety of organisms as important effector molecules involved in innate immunity. They are characterized by their small size [12-50 amino acids (AAs)], their positive net charge due to the presence of arginine and lysine residues, and their amphipathic structure, which enables their interaction with microbial membranes [1] [2] [3] [4] . In addition to AMP involvement in innate immunity against infective pathogens in a direct manner, they are also indirectly involved in modulating innate immunity through the induction of chemokine production and the regulation of apoptosis, angiogenesis, and wound healing [5, 6] . Moreover, a certain type of AMPs (e.g., Drosophila antifungal peptide, drosomycin) is capable of interaction with voltage-gated ion channels exerting bioactivity as toxins [7, 8] . It was recently proposed based on a combination of evolutionary, structural, and mechanistic data that defensins, a type of AMP, could share a common ancestor with animal toxins [9] [10] [11] [12] . In this regard, the discovery of new AMPs from a basally branching metazoan would offer valuable insight into ancient molecular features and help understand how host defense and toxin peptides can be categorized, findings which could eventually be utilized for the development of antiinfectives or other therapeutics.
Phylum Cnidaria, a sister clade of Bilateria, is one of the earliest known phyletic lineages and comprises remarkably diverse and ecologically significant taxa, including sea anemones, corals, jellyfish, and hydras [13] . These Cnidarians use only two epithelial barriers (e.g., ectodermal and endodermal epithelium), with peptide antibiotics as their first line of defense, because the traditional protection system present in bilaterians, such as impermeable barriers, hemolymphs, and migratory phagocytic cells, is absent in these animals [14, 15] . Nevertheless, Cnidarians do not appear vulnerable to viruses, bacteria, protists, or parasites, even though they live in habitats full of these microorganisms and are constantly exposed. This suggests that these animals should have numerous immune effectors, such as AMPs, to defend against microbial pathogens [16] . For example, hydramacin-1, arminin-1a, and periculin-1 identified from Hydra magnipapillata exhibit potent and broad-spectrum activity against bacteria, including multiresistant human pathogenic bacteria, and do not share sequence homology with other known AMPs [17] [18] [19] . Aurelin and damicornin, recently identified from jellyfish (Aurelia aurita) and coral (Pocillopora damicornis), respectively, also show no sequence homology with other known AMPs, although they do share a number of key features with invertebrate defensins and some sea anemone neurotoxins (e.g., ShK, HmK, and BgK) [20, 21] . Although no AMP has been identified from sea anemones, due to a peculiar position among venomous animals, sea anemones have thus far been extensively studied for their peptide neurotoxins, including voltage-gated Na + -and K + -channel-blocking toxins [22] [23] [24] [25] . Therefore, identifying AMPs from sea anemone could offer valuable insight into their evolution and function based upon structural features that could be fundamental to the development of anti-infectives or other therapeutics. We recently evaluated the antimicrobial activity of various tissue extracts, including mucus, from northern Pacific sea anemone (Urticina crassicornis) against gram-positive and gram-negative bacteria. The antimicrobial activity of all tissue extracts was evident without any hemolytic activity against human red blood cells, but was completely abolished by treatment with proteolytic enzymes, suggesting that the extracts contained proteinaceous antimicrobial materials and represent a proper source for biochemical isolation of AMPs [26] .
Here, we described the isolation and characterization of the first two novel AMPs from extracts of the sea anemone U. crassicornis pharynx. The two purified AMPs, designated as Crassicorin-I and II, share no sequence homology with other known AMPs, but do share structural features with sea anemone BDS-like neurotoxins, a new family of sea anemone peptide toxins that have six cysteine residues forming three disulfide bridges [22] . A cDNA encoding the Crassicorin-I precursor protein was cloned and sequenced, enabling an investigation of its distribution and expressional regulation following immune challenge in U. crassicornis tissues. Recombinant Crassicorin-I (rCrassicorin-I) produced through a bacterial-expression system with refolding procedures was identical to the native peptide and exhibited antimicrobial activity against gram-positive and gram-negative bacterial strains. In the context of structure similarity between Crassicorin-I and neurotoxins, we evaluated its paralytic activity against shrimp (Palaemon paucidens) and, moreover, investigated antimicrobial activity of neurotoxins (APETx1 and ShK) identified from other sea anemones.
Results and Discussion
Purification of two AMPs from the pharynx extract of Urticina crassicornis
The pharynx extract was used as a source to purify AMPs from U. crassicornis, with the extract showing antimicrobial activity against gram-positive bacterium (Bacillus subtilis KCTC1021) and gram-negative bacterium (Escherichia coli D31; Fig. 1A ). In the initial purification step using preparative continuous-acid urea-polyacrylamide gel electrophoresis (CAU-PAGE), fractions between 170 and 360 mL eluted with 5% acetic acid, which were approximately the second half of the eluates, showed antimicrobial activity against both B. subtilis and E. coli (Fig. 1B) . The broad range of fractions exhibiting antimicrobial activity implied that the pharynx extract contained antimicrobial components, including AMPs of various charge and molecular size. Among the active fractions, fraction 21 eluted from 200 to 210 mL exhibited the most potent antimicrobial fraction and was used for subsequent experimentation. This fraction was subjected to the next purification step involving RP-HPLC, revealing two separate absorbance peaks [peak A was eluted with 34% acetonitrile/0.1% trifluoroacetic acid (TFA) at 36.2 min, and peak B was eluted with 35% acetonitrile/0.1% TFA at 37.9 min] exhibiting antimicrobial activity against B. subtilis (Fig. 1C) . Contents of the purified samples migrated to between 4 and 5 kDa according to 16% Tricine SDS/PAGE (Fig. 1D) , indicating that the purified peptides were similar in size.
Analysis of the primary structures of the purified AMPs
The first 34 or 36 N-terminal AA residues of the purified peptides were obtained by automated Edman degradation and were as follows: peak A, GASXDXHPFKGTYWFGTSNXPSGHGYRKKXDS FF (34 AAs); and peak B, GASXDXHPFVGTYWF GISNXPSGHGYRKKXASFFGV (36 AAs) (X represents unidentified residues returning blank cycles during Edman sequencing) ( Fig. 2A) . The molecular masses of peaks A and B as determined by MALDI-TOF mass spectrometry (MS) were 4386.4 and 4313.8 Da according to protonated molecular ions (M+H) + , respectively (Fig. 2B,C) . Unidentified AAs, such as cysteine residues, emerged as blank cycles during AA-sequencing procedures in the absence of the reduction and alkylation steps, with these cysteine residues commonly forming disulfide bonds in AMPs to enhance folding and stability. The purified peptides were reduced by treatment with 1,4-dithiotreitol (DTT) to confirm the existence of disulfide bonds. Following reduction, the retention times of peaks A and B shifted from 20.4 to 19.3 min and from 22.4 to 21.8 min (Fig. 2D,E) , respectively, and the molecular masses of both peptides increased by 6 Da (Fig. 2F,G) . These data indicated that both peptides contained six cysteine residues, which formed three intramolecular disulfide bonds. Despite the replacement of four unidentified residues with cysteine residues and the inclusion of two additional cysteine residues into both peptides to enable the formation of three disulfide bonds, the theoretically calculated molecular masses did not correspond with those obtained experimentally, suggesting there are likely two to four additional AA residues at the C termini of the determined sequences of peaks A and B. Moreover, we regarded peak A as a homolog of peak B, because both peptides exhibited almost identical primary structures, including the three disulfide bonds and except for the three AAs at positions 10, 17, and 31. Three charged or polar residues (Lys from the same locations in the sequence of peak B ( Fig. 2A) while the antimicrobial activity of both peaks A and B against B. subtilis was not abolished by these substitutions (Fig. 1C) suggesting the residues involved may not be crucial for antimicrobial activity of the peptides. The effect of these substitutions on mechanism for antimicrobial activity of the peptides against other bacteria needs to be studied further.
Crassicorin-I is generated from a large precursor, preproCrassicorin-I To determine the complete primary structures of and clone both peaks A and B, cDNA cloning was conducted using degenerate primers, with the degeneracy of codons associated with both peptides. It was found, however, that the cDNA encoding peak B was preferentially cloned and sequenced (Fig. 3A) . Peak B was designated as U. crassicornis AMP Crassicorin-I (GenBank accession number: KY229683), and peak A was designated as Crassicorin-II, which was subsequently determined to be a homolog of Crassicorin-I. The cDNA sequence encoding the Crassicorin-I precursor comprised 512 bp, starting with a 5 0 -UTR of 72 bp, followed by an open reading frame (ORF) of 237 bp, ). The mature Crassicorin-I was a cationic AMP with a calculated isoelectric point of 8.65 and a theoretical molecular mass of 4320. 9 Da, which agreed with the experimentally obtained molecular mass of the reduced Crassicorin-I. A typical cationic AMP is expressed as a large precursor called a prepropeptide consisting of a signal peptide at the N terminus for translocation to the endoplasmic reticulum, an anionic prosequence for neutralizing positively charged mature peptides or transport into the secretory organelle (e.g., cnidocytes in cnidarian), and a mature peptide harboring the site of activity [2, [27] [28] [29] . Similarly, cnidarian AMPs identified from Hydra, Aurelia, and Pocillopora were also generated from their precursors (Fig. 3B) [18, 20, 21] . These data indicated that proteolysis of the precursor led to the formation of mature Crassicorin-I, wherein six cysteine residues form three disulfide bonds to allow proper folding and antimicrobial activity.
Crassicorin-I is the first AMP identified from sea anemone sharing structural features with BDSlike neurotoxins belonging to b-defensin fold family
The deduced AA sequences of the Crassicorin-I precursor and mature Crassicorin-I obtained through cDNA cloning were submitted as queries against the nonredundant protein sequences in the NCBI database using BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi). We found no significant sequence homology with other known AMPs. The mature peptide was characterized via Pfam (http://pfam.xfam.org/) and InterPro (https:// www.ebi.ac.uk/interpro/) as a member of defensin 4 domain family, which includes myotoxins/anemone neurotoxins. Consistently, numerous hits aligned with precursors of neurotoxin peptides belonging to the ion channel-blocking toxin family previously described in the sea anemones Anemonia viridis and Bunodosoma granuliferum (Fig. 4A) [23, [30] [31] [32] . The mature form of Crassicorin-I showed high degrees of sequence identity with various sea anemone neurotoxins, including BcIV (49%), Bcg31.16 (50%), U-AITX-Bg1b (53%), APETx1 (47%), APETx2 (41%), and BDS-I (34%), that were recently classified into a new sea anemone neurotoxin family (Fig. 4B ) [22] . These neurotoxins contain six highly conserved cysteine residues exhibiting consensus cysteine spacing (X n CXCX 12-15 CX 9-10 CX 6 CCX n ) and C1-C5, C2-C4, and C3-C6 connectivity representing three disulfide bonds promoting adoption of the overall b-defensin-fold structure [23, [32] [33] [34] [35] .
Defensins represent an extensive family of cationic AMPs, discovered in diverse species of fungi, plants, invertebrates, and vertebrates, that are generally characterized by six or eight cysteine residues forming three or four intramolecular disulfide bonds, respectively ( Fig. 5A) [2, 12, [36] [37] [38] . Aside from the presence of cysteine residues, defensins exhibit neither conserved residues nor a given number of residues located between cysteines. Although the evolutionary relationship of these family still remains obscure, the most recent study on the origin of defensin family suggested the existence of two independent ancestors: one containing cysteine-stabilized ab (CSab)-fold for defensins from plants, fungi, and invertebrates and the other containing b-defensin fold for vertebrate a-and bdefensins and invertebrate big-defensins [39] . Meanwhile, many toxins are small and cationic peptides that contain multiple disulfide bonds for structural stability and share a striking degree of conservation of structural scaffold with CSab defensins and b-defensin family suggesting that toxins share common ancestor with defensins [9] [10] [11] [12] .
Defensin-like AMPs with cysteine connectivity (C1-C6, C2-C4, and C3-C5) identified thus far from cnidarian species (e.g., aurelin and damicornin) share a common ancestor and key structural features, including CSab motifs, with invertebrate defensins exhibiting cysteine connectivity (C1-C4, C2-C5, and C3-C6) (Fig. 5B) [20, 40] . In contrast, Crassicorin-I exhibits cysteine arrangement differing from that of cnidarian ) corresponds to the cysteine connectivity found within AMPs (e.g., human b-defensin) and neurotoxins (e.g., BDS-I and APETx2) of the b-defensinfold family (C1-C5, C2-C4, and C3-C6) (Fig. 5C) . Therefore, Crassicorins are likely to be classified into a b-defensin-fold family of AMPs rather than the invertebrate defensin family. Collectively, Crassicorins are the first AMPs identified from the sea anemone U. crassicornis which seem to share the primary structure, cysteine pattern, and b-defensin fold with BDS-like neurotoxins. It seems that the origin of b-defensin-fold AMPs may be traced back to sea anemones belonging to the lineage of Cnidaria, which branched prior to the diversification of bilaterians into the variety of animal groups currently known.
Crassicorin-I is involved in the defense mechanism against infectious bacteria Among cnidarian AMPs, Hydra AMPs, including hydramacin, arminin, and periculin, are expressed in the granular cells of both the endoderm and ectoderm, and damicornin is specifically expressed in the granular cells of the ectoderm in coral [14, 18, 20] . Although the expression of these AMPs is responsible for epithelial defense against infectious pathogens, the origin of sea anemone AMP production remains unanswered. The basal transcription levels of the Crassicorin-I precursor in different tissues (pharynx, tentacle, gonad, mesenteries, and pedal disk) of U. crassicornis were determined by real-time quantitative polymerase chain reaction (RT-qPCR) (Fig. 6A ) using gene-specific primers targeting the Crassicorin-Icoding region. A sea anemone b-actin gene, which is not only an adequate housekeeping gene but the most stable gene in a sea anemone [41] , was used as an invariant control and for comparison of relative expression between transcripts. The highest expression level of Crassicorin-I-precursor transcripts was detected in the mesenteries. Additionally, a relatively high expression level was also observed in the pharynx, which was the source of Crassicorin-I isolation. However, the expression in the tentacle was barely detectable. The functional significance of the mesenteries located inside the gastrovascular cavity of the sea anemone has been elucidated that as they carry the gonads, secretory gland cells and nematocytes, they are of pivotal importance for reproduction and digestion [42, 43] . Moreover, previous immunohistochemical and cytobiochemical analyses of the mesenteries from sea anemones demonstrated intense staining of cnidocytes and potent antimicrobial properties [44, 45] , suggesting that the mesenteries play an important role in production of immune-effector molecules in sea anemones. Notably, AMPs expressed in the granular cells of the endoderm and/or ectoderm in cnidarian were upregulated by infectious pathogens following activation of signal-transduction pathways [14, 15] . Therefore, we analyzed the relative amount of Crassicorin-I-precursor transcripts in the pharynx and the mesenteries of U. crassicornis at 0, 4, 8, 16 , and 32 h after immune challenge. We observed that Crassicorin-I mRNA expression peaked at 8 h (a 6.5-fold increase from 0 h) in mesenteries and at 16 h (a 2.5-fold increase from 0 h) in the pharynx postchallenge, followed by a gradual decline Fig. 6 . Crassicorin-I precursor transcript expression levels in Urticina crassicornis. Basal expression profiles in various tissues (A). Expression levels in mesenteries and the pharynx following immune challenge (B). Relative expression levels of Crassicorin-I transcripts in each tissue normalized against b-actin levels. Data represent the mean AE standard deviation (n = 3) denoted by statistically significant differences (a, b, c, d, and e; P < 0.05) between tissues as determined by one-way ANOVA, followed by Duncan's multiple-range test.
( Fig. 6B) . Overall, we observed that the Crassicorin-I transcript was mainly expressed by certain cells in the mesenteries and pharynx in U. crassicronis, and that the expression was upregulated by infectious bacteria, indicating that Crassicorin-I was likely involved in a first-line defense mechanism against infectious pathogens during reorganization of the sea anemone body.
Recombinant production of Crassicorin-I and assessment of its antimicrobial activity
The investigation of biological activities required sufficient amounts of Crassicorin-I; therefore, recombinant Crassicorin-I (rCrassicorin-I) was overexpressed in E. coli BL21(DE3) cells transformed with a laboratory modified pET28a-thioredoxin A (TrxA)-fused Crassicorin-I construct (Fig. 7A) . Recombinant His6-tagged TrxA fused with Crassicorin-I was purified by affinity chromatography from bacterial cell lysates under denaturing condition (Fig. 7B) . The chemically cleaved and reduced rCrassicorin-I was confirmed using the Nterminal sequence analysis. The chemical properties and molecular mass of the refolded rCrassicorin-I were compared with those of Crassicorin-I obtained from extracts via RP-HPLC and MALDI-TOF MS, respectively. The mixture of rCrassicorin-I and Crassicorin-I was coeluted and merged as a single absorbance peak via RP-HPLC (Fig. 7C) , with the molecular mass of rCrassicorin-I measuring 4313.6 Da, which agreed with that of Crassicorin-I (4313.8 Da) (Fig. 7D ) and demonstrated that rCrassicorin-I was successfully produced in the heterologous system, with the six cysteine residues in the peptide paired accordingly.
The most potent antimicrobial activity of rCrassicorin-I was observed against B. subtilis at a minimal effective concentration (MEC) of 11.49 lgÁmL À1 , and moderate antimicrobial potency was observed against E. coli and Salmonella enterica (Table 1) . [46, 47] . Consistently, rCrassicorin-I exhibited antimicrobial activity against some gram-positive and -negative bacteria, which might be associated with its specific AA sequence and affinity to certain molecules present in the microbial membrane.
Crassicorin-I functions as a neurotoxin
The molecular structure of Crassicorin-I, including six cysteine residues forming three intramolecular disulfide bonds, was identical to that of sea anemone neurotoxins characterized by b-defensin folds (Figs 4B and 5C ). Additionally, Crassicorin-I and these neurotoxins shared overall sequence homology with one another along with several conserved residues, including Gly , and Tyr 26 (numbering taken from the Crassicorin-I sequence) (Fig. 4B) . Structural alignment suggested that Crassicorin-I might function not only as an AMP but also in a fundamental role as a neurotoxin to immobilize prey. Therefore, it is necessary to demonstrate the potential role of Crassicorin-I as a neurotoxin. To this end, rCrassicorin-I toxicity (lethality and paralysis) was preliminarily evaluated using a crustacean (the freshwater shrimp Pa. paucidens). A simple assay testing toxicity to prey animals has been widely accepted as a test for the detection of sea anemone neurotoxins [23, 33, 48, 49] . Moreover, AA substitutions among the homologous toxins responsible for the extremely divergent targets made it difficult to determine the proper target channel for rCrassicorin-I. For example, BcIV paralyzes crabs, BDS-I targets K V 3-and Na + -ion channels, APETx1 targets human ether-a-go-go-related gene (hERG) channels and Na + -ion channels, and APETx2 blocks hERG, acid-sensing ion channel 3 (ASIC3) and Na + -ion channels (Fig. 4B) [50, 51] . rCrassicorin-I toxicity was determined to be nonlethal and caused only temporary paralysis upon administration of all tested dosages (Fig. 8) . The median effective dose (ED 50 ) for paralytic activity was 0.84 AE 0.16 lgÁg À1 shrimp body weight, and the minimum dose required for complete paralysis was observed starting from 2 lgÁg À1 shrimp body weight (Fig. 8B ). All shrimp became paralyzed immediately following injection of rCrassicorin-I (2 lgÁg À1 shrimp body weight) and remained unable to move for the following 2 h (Movie S1). Sea anemones produce neurotoxins capable of allowing these sessile animals to paralyze and move their prey toward their mouth for digestion inside the gastrovascular cavity. Neurotoxins prolong the action potential of the excitable and nonexcitable membranes in sensory neurons and in cardiac and skeletal muscle cells via modification of Na + -channel gating or by blocking K + -channel gating during the repolarization stage [25, [52] [53] [54] . Therefore, these results implied rCrassicorin-I-induced paralysis relies upon blocking neural impulses generated via ion channels in the nerve fibers of prey animals.
Crassicorin-I shares a spatially distinct feature with AMPs and neurotoxins
Cysteine-rich AMPs and toxins folded with the aid of disulfide bonds generally exhibit distinct threedimensional (3D) structures with striking degrees of similarity despite disparate biological activities and minimal shared AA sequence identity. However, Crassicorin-I exhibits activities associated with both AMPs and toxins. Therefore, we generated a molecular model of Crassicorin-I using Swiss-Model (https://swissmode l.expasy.org/) to investigate relationships between spatial structure and activity. The Crassicorin-I model was created using the APETx2 (PDB ID: 1WXN) structure as a template, resulting in a structure exhibiting significant absolute model quality (QMEAN Zscore: À1.40; https://swissmodel.expasy.org/qmean/) and a root mean square deviation of 0.369 A (PYMOL; https://www.pymol.org/). The resulting 3D structure showed that Crassicorin-I was closely compacted by a core comprising three antiparallel stranded b-sheets (Fig. 9A) . This structural feature resembles that of the b-defensin fold characterized by the presence of a turn adjacent to three antiparallel b-strands, as well as disulfide bonds formed by the six cysteines (C1-C5, C2-C4, and C3-C6) [55] . In agreement with the primary structure alignment (Figs 4B and 5C), the model structure showed three disulfide bonds consisting of Cys 4 
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-Cys 38 (corresponding to C1-C5, C2-C4, and C3-C6, respectively), and connectivity similar to that found in vertebrate b-defensins, invertebrate big-defensins, and b-defensinfold toxins (Fig. 9B,C) [56] . Additionally, the Crassicorin-I model showed two faces: one face was composed of several basic residues (His (Fig. 9D,E) . The homology structure reflects characteristics of amphipathic AMPs, including defensins, which contain clusters of positively charged AA residues and hydrophobic AA residues that allow them to interact with negatively charged phospholipid head groups and hydrophobic fatty acid chains in microbial membranes [36] . The Crassicorin-I model displayed a cluster of aromatic residues (Phe ) similar to those of APETx2 (Fig. 9F) . Recent study of structure-activity for APETx2 suggests that a pharmacophore consisting a cluster of aromatic and basic residues is crucial for its interaction with ASIC3 and some of these residues are also responsible for inhibition of hERG [57] . This implies that a pharmacophore in the Crassicorin-I model might recognize putative target channels to exhibit its neurotoxic activity toward their prey animals.
Unveiling antimicrobial activity from sea anemone neurotoxins
The data presented here suggest possible functional consolidation of antimicrobial and neurotoxic activity; however, it remains unknown whether this is a unique characteristic of U. crassicornis Crassicorin-I or shared among known neurotoxins. To investigate this possibility, we evaluated antimicrobial activity using two commercially available neurotoxins, APETx1 and ShK, identified from sea anemones Anthopleura elegantissima and Stichodactyla helianthus, respectively [34, 58] . APETx1, a b-defensin-fold toxin, specifically inhibits hERG channels [34, 59] , and shares similar structural features with Crassicorin-I (Figs 4B, 5C and 9B,F). In contrast, ShK adopts a central helix-kinkhelix motif, structurally similar to the invertebrate defensin-like cnidarian AMPs aurelin and darmicornin, and blocks voltage-dependent K + -ion channels [20, 21, 60] . The evaluation and comparison of antimicrobial activity between these peptides were conducted using 5 lL of 0.5 mM peptide against gram-positive bacteria B. subtilis and St. aureus and gram-negative bacteria Sa. enterica and Ps. aeruginosa and HNP-1 was used as a control (Fig. 10) . Our results showed that APETx1 exhibited higher antimicrobial activity than Crassicorin-I only against the gram-negative bacterium Sa. enterica, whereas ShK demonstrated broadspectrum antimicrobial activity comparable with that of HNP-1 against all tested bacteria. The observed selectivity of antimicrobial activity might be a consequence of structural diversity among the peptides. Overall, the antimicrobial activities of these neurotoxins suggested that sea anemone neurotoxins might also be involved in defense mechanisms associated with these basally branching metazoans. Antimicrobial peptides and toxins have attracted considerable attention in recent years due to their potential applications as therapeutics. Previous studies reported that despite the differences in their targets and interacting molecules, each group (AMPs or toxins) consists of strikingly similar molecular structures and physiochemical characteristics. These include cationicity often coupled with amphipathicity, with AMPs targeting microbial membranes and interacting with lipids in a semispecific way, whereas toxins target proteins in eukaryotic cell membranes and interact 
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The FEBS Journal 284 (2017) 3320-3338 ª 2017 Federation of European Biochemical Societies specifically with certain receptors [9, 10, 12, 61, 62] . Many defensins exert considerable cytotoxicity in cell and animal models [3, 63] , whereas neurotoxins produce unexpected effects in mammals by interacting with offtargets [64, 65] . To overcome these impediments to the development of therapeutics associated with these peptides, further investigations are required to provide deeper insight into the origins of and structural and functional reciprocity between AMPs and toxin molecules.
This study represents the first reported isolation and characterization of two novel BDS neurotoxin-like AMPs, designated as Crassicorin-I and its homolog Crassicorin-II, from the sea anemone U. crassicornis belonging to the phylum Cnidaria. Furthermore, we evaluated the biological activity of Crassicorin-I through assays involving rCrassicorin-I, revealing antimicrobial activity and neurotoxin-related paralyzing effects on shrimp Pa. paucidens. These findings suggested a common evolutionary history between bdefensin fold AMPs related to neurotoxin activity in basally branching metazoans. Therefore, these results provided valuable insights into the potential consolidation of antimicrobial activities in known sea anemone neurotoxins, thereby benefiting research into possible reciprocal relationships between AMPs and toxins that could aid the development of anti-infectives or other therapeutics.
Materials and methods
Animals
Live sea anemones (U. crassicornis; diameter, 7-9 cm; height, 5-6 cm; wet weight, 400-500 g) were commercially obtained from Gijang in Busan, Korea, and maintained in a recirculating seawater system at 12°C until use without prey feeding. Live specimens of the shrimp species Pa. paucidens (body length, 3-4 cm; body weight, 0.5-0.7 g) were purchased from a shrimp farm in Gyeongju, Korea, and maintained in a freshwater aquarium with constant aeration at 24°C for analysis of paralysis by AMP. The shrimp were fed daily with commercial shrimp meal. Approval by the local institution/ethics committee was not required for this work, because experimental work on sea anemones and shrimp are not subject to regulation.
Sample extraction from the pharynx of Urticina crassicornis
Six sea anemones (U. crassicornis) were dissected, and the pharynx under the mouth with in-folding body wall epidermis was collected. The tissue was cut into pieces and immediately soaked in four volumes of preheated distilled water containing 1% acetic acid in a double boiler for 5 min to denature proteins and inhibit proteolytic enzyme activity. The boiled tissue was cooled on ice and then completely homogenized (PT10-35; Kinematica AG, Luzern, Switzerland). The homogenate was centrifuged (13 000 g, 25 min, 4°C), and the supernatant was concentrated using a rotary evaporator.
Continuous-acid urea-polyacrylamide gel electrophoresis
The crude pharynx extract was subjected to preparative CAU-PAGE using a Bio-Rad Prep Cell 491 (Bio-Rad Laboratories, Richmond, CA, USA) for initial purification according to a previously described method [66] . Briefly, 10 mL of the extract mixed with a 5 mL of sample load solution (3.0 M urea in 5% acetic acid) was transferred onto a 12% acrylamide acid-urea gel containing 5% acetic acid and 4.8 M urea and electrophoresed at a constant current of 30 mA in 5% acetic acid at room temperature. Elution was performed with a flow rate of 0.83 mLÁmin À1 for 7 h, and 10 mL fractions were collected. After the elution, each fraction was lyophilized and then redissolved in 200 lL of 0.01% acetic acid. A portion of each fraction (5 lL) was tested for antibacterial activity against Fig. 10 . Antimicrobial activity of sea anemone neurotoxins. Each peptide (5 lL of 0.5 mM) was tested by URDA. APETx1 is a neurotoxin homolog of Crassicorin-I classified in the b-defensin-fold family. ShK is a sea anemone neurotoxin, homolog of aurelin and damicornin identified from jellyfish and coral, respectively, and is classified into the CSab-fold family. HNP-1 was used as a control.
B. subtilis KCTC1021 using an ultrasensitive radial-diffusion assay (URDA) as described later in this section.
AMP purification by RP-HPLC
A fraction (number 21) that eluted at between 200 and 210 mL of 5% acetic acid exhibited potent antimicrobial activity against B. subtilis. The fraction was subjected to RP-HPLC (Capcellpak C18; 4.6 9 250 mm; Shisheido Co., Tokyo, Japan), and elution was performed with a linear gradient of 5% to 65% acetonitrile/0.1% TFA at a flow rate of 1 mLÁmin À1 for 60 min. Two peaks showing antimicrobial activity were eluted at between 34% and 35% acetonitrile/0.1% TFA. The active peaks were purified by chromatography again using the same column as the previous step, but with isocratic elution at 34% (peak A) and 35% acetonitrile/0.1% TFA (peak B) at a flow rate of 1 mLÁmin À1 , and their absorbance peaks were preferentially analyzed to approximate their molecular sizes using 16% Tricine SDS/PAGE. The samples were then subjected to further analyses of their molecular mass and AA sequence.
Structural determination of purified AMPs
To determine the molecular masses and AA sequences of the purified AMPs from U. crassicornis, we used an automated N-terminal AA gas-phase sequencer (PPSQ-31A/33A protein sequencers; Shimadzu Co., Kyoto, Japan) and a UltrafleXtreme MALDI-TOF MS equipped with a pulsed smartbeam II (355 nm Nd:YAG laser-repetition rate: 1 kHz) in linear mode (Bruker Daltonics, Billerica, MA, USA). The existence of disulfide bonds in the purified peptides was confirmed by reduction with 100 lL of 100 mM DTT solution for 2 h at 42°C; the retention times of the reduced and the native peptides during coelution by RP-HPLC with a linear gradient of 20-50% acetonitrile/0.1% TFA for 30 min at a flow rate of 1 mLÁmin À1 were compared.
cDNA cloning
Cloning of the cDNA encoding the purified AMPs designated Crassicorin-I and II was performed by 3 0 and 5 0 rapid amplification of cDNA ends (RACE). Total RNA was extracted from U. crassicornis pharynx tissue using the Hybrid-R kit (GeneAll, Seoul, Korea), and mRNA was purified using an Oligotex mRNA mini kit (Qiagen, Hilden, Germany) according to manufacturer instructions. The synthesis of RACE-ready cDNA templates was performed using the GeneRacer kit (RLM-RACE; Invitrogen, Carlsbad, CA, USA) according to manufacturer instructions. Based on the AA sequence (His-Pro-Phe-Lys/Val-Gly-ThrTyr-Trp-Phe-Gly) of the purified AMPs, two degenerate primers were designed for 3 0 RACE (primer sequences used for RACE are listed in Table S1 ). Recombinant expression, purification, and refolding of rCrassicorin-I rCrassicorin-I was obtained according to the method described for recombinant human neutrophil a-defensin production [67] , with a slight modification to the expression-vector system introduced by our laboratory. A pET28a-TrxA fusion vector comprising an N-terminal His6-tag fused with E. coli TrxA was constructed. The Crassicorin-I coding cDNA sequence was amplified by PCR using the forward primer Cr-EcoRI-Met-Fw denoted by a Met codon to incorporate a cyanogen bromide (CNBr) cleavage site immediately upstream of the N terminus of mature Crassicorin-I and the reverse primer Cr-SalIRv (primer sequences are listed in Table S1 ). The PCR product was cloned in-frame with the N-terminal His6 tag using the EcoRI/SalI sites of the pET28a-TrxA fusion vector and verified by sequencing. The pET28a-TrxA/Crassicorin-I vector was transformed into E. for 8 h in darkness at 25°C. The cleavage reaction was terminated by adding 10 volumes of water, followed by lyophilization. The cleaved fusion-peptide mixture was reduced in 100 mM Tris-HCl buffer (pH 8.0) in the presence of 100 mM DTT, followed by purification by RP-HPLC (Capcellpak C18; 4.6 9 250 mm; Shisheido). A peak predicted to be rCrassicorin-I was collected and lyophilized, and the AA sequence of rCrassicorin-I was confirmed by analyzing the first three AA residues using an automated N-terminal AA gas-phase sequencer (Shimadzu Co.). Lyophilized peptides were folded in 0.1 M NaHCO 3 buffer (pH 8.1) containing 3 mM reduced and 0.3 mM oxidized glutathione, 2 M urea, and 25% N,N-dimethylformamide at room temperature for 72 h. Refolded rCrassicorin-I was purified to homogeneity by RP-HPLC and its molecular mass and chemical property, via MALDI-TOF MS and RP-HPLC, were compared with those of Crassicorin-I purified from the U. crassicornis extract.
Antimicrobial assay
Ultrasensitive radial diffusion assay was used to monitor antimicrobial activity during purification and for determination of rCrassicorin-I MEC as described previously [66, 68, 69] . The antimicrobial activities of sea anemone neurotoxins APETx1 and ShK and human neutrophil defensin-1 purchased from Pepetide, Inc. (Osaka, Japan) were also tested. Microbial strains included the gram-positive bacteria B. subtilis KCTC1021 and St. aureus KCTC1621, gram-negative bacteria Ps. aeruginosa KCTC2004, E. coli D31, and Sa. enterica ATCC13311, and the fungal strain C. albicans KCTC7965. Briefly, microbial strains were precultured overnight in tryptic soy broth (TSB) at 37°C and diluted with phosphate buffer (PB; pH 6.6) to a McFarland turbidity standard of 0.5 (Vitek Colorimeter #52-1210; Hach, Loveland, CO, USA) corresponding tõ 10 8 CFUÁmL À1 for bacteria and~10 6 CFUÁmL À1 for C. albicans, and 0.5 mL of the diluted strains was mixed with 9.5 mL of underlay gel containing 0.03% TSB and 1% Type I (low electroendosmosis) agarose in 20 mM PB (pH 6.6), followed by transfer to a square petri dish with grids making the microbial concentration of the underlay gel into 5 9 10 6 CFUÁmL
À1
. Each sample in 5 lL of 0.01% acetic acid was added to 2.5-mm-diameter wells made in the 1-mm-thick underlay gel. After complete diffusion of each sample for 3 h at room temperature, underlay gels containing microbial strains were overlaid with 10 mL of 6% TSB and 1% agarose in 20 mM PB (pH 6.6). Plates were incubated for 16 h at the appropriate temperature for growth of microbial strains, and the diameters of the clear zones were measured. After subtracting the diameter of the well, the clear-zone diameter was expressed in units (0.1 mm = 1 U). MECs (lgÁmL
) of the purified peptide were calculated as the X-intercept of a plot of units against the log 10 of the peptide concentration [69] .
Real-time quantitative polymerase chain reaction
Five tissues, including the pharynx, tentacle, gonad, mesenteries, and pedal disk, were collected from three normal, healthy U. crassicornis specimens. To investigate induction of Crassicorin-I by microbial infection, U. crassicornis was challenged at different sites through the pharynx by injecting 300 lL of B. subtilis at an OD 600 of 0.1, followed by collection of the pharynx and mesenteries at 0-, 4-, 8-, 16-, and 32-h postinjection. Injection of sterilized PBS was used as a control. Total RNA was extracted from the collected tissues using Hybrid-R (GeneAll, Seoul, Korea), and RNA quality was assessed by 1.0% agarose gel electrophoresis and then quantified spectrophotometrically using a NanoDrop Lite (Thermo Fisher Scientific, Wilmington, MA, USA). cDNA was synthesized using the TOPscript cDNA synthesis kit with oligo dT (dT18; Enzynomics) according to manufacturer instructions. To validate differences in Crassicorin-I mRNA-transcript expression in tissues or postimmune challenge, RT-qPCR was employed using a CFX Connect real-time PCR detection system (Bio-Rad Laboratories) as previously described, with slight modifications [70] . Briefly, amplification was performed in 20 lL volume reactions containing 10 lL of 29 SYBR Green premix (TOPreal qPCR 29 PreMix; Enzynomics), 1 lL (10 pmolÁlL À1 ) of each gene-specific forward and reverse primer, 1 lL of 10-fold-diluted cDNA template, and nuclease-free water added to make a final volume of 20 lL. Primer pairs used for amplifying Crassicorin-I-precursor, with sea anemone b-actin (accession no.: 156375339) cDNA as a control for normalization, were Crassicorin-I qPCR-F and -R and b-actin qPCR-F and -R, respectively (Table S1 ). The thermal-cycling profile was 95°C for 10 min, followed by 40 cycles at 95°C for 10 s, 60°C for 15 s, and 72°C for 15 s, with fluorescence recording at the end of each cycle. Melting-curve analysis was performed to ensure product specificity over the temperature range 60°C to 90°C. Amplicons were analyzed on agarose gels to confirm product size. Based on the standard curves for both Crassicorin-I and b-actin, the relative expression levels of Crassicorin-I-precursor transcripts in each tissue and at each time point were normalized against the level of b-actin using the comparative CT method (2 ÀDDCT ) [71] . Triplicate cDNA sample amplifications were performed independently, and the results were statistically analyzed.
Computational analyses
The sequences obtained were translated into protein sequences using ExPASy (http://web.expasy.org/translate/), and SignalP 4.1 (http://www.cbs.dtu.dk/services/SignalP/) was used to predict the signal peptide of the translated protein sequence. Theoretical isoelectric point and molecular weight of the translated mature peptides were determined using ExPASy. Multiple-sequence alignment of the fulllength precursors and/or mature peptides were aligned using BLAST (http://blast.ncbi.nlm.nih.gov/blast.cgi), and CLUSTAL OMEGA (http://www.ebi.ac.uk/Tools/msa/clustalo/) was used for multiple-sequence alignment of Crassicorin-I and related sequences [72] . Pfam (http://pfam.xfam.org/) and InterPro (https://www.ebi.ac.uk/interpro/) were used for the classification of family of Crassicorin-I. Homology modeling was performed using Swiss-Model (https://swissmodel.expasy.org/) in automated mode using template and Crassicorin-I sequences [73] . The 3D structures of some toxins and defensins were downloaded from the Protein Data Bank (http://www.rcsb.org/pdb/). The estimated accuracy of the models was validated through the structure assessment tools (Anolea, Dfire, Qmean, Gromos, Procheck, and Promotif) available in Swiss-Model (http://swissmodel.expasy.org/workspace/) [73] [74] [75] [76] [77] [78] [79] . PYMOL (v1.2, 254; http://www.pymol.org/) was used for examination and calculation of electrostatic potentials.
Toxicity testing of rCrassicorin-I on shrimp
To evaluate rCrassicorin-I toxicity (lethal or paralytic activity), freshwater shrimp (Pa. paucidens) was used according to a modified procedure described previously [33] . Briefly, rCrassicorin-I was dissolved with 19 PBS (pH 7.4) and injected into the junction between the carapace and first abdominal segment of the shrimp. The tested concentrations were 0, 0.5, 1, 2, and 4 lg rCrassicorin-I for 1 g shrimp body weight. Groups of 10 shrimp were challenged with various doses of rCrassicorin-I, and the symptoms induced were carefully observed for up to 2 h postinjection. The lethal (LD 50 ) or paralytic (ED 50 ) activity was determined via fitted sigmoidal curves using GRAPHPAD PRISM (v7.0 for Windows; GraphPad Software, San Diego, CA, USA).
Statistical analysis
For statistical analysis of Crassicorin-I-precursor transcript expression, graphs were generated, and one-way analysis of variance (ANOVA) with Duncan's multiple-range post hoc analysis was performed using GRAPHPAD PRISM (v7.0 for Windows; GraphPad Software). Relative fold expression was presented as the mean AE standard deviation. A P < 0.05 was considered statistically significant.
